Trial Information

Summary: Phase 4 Medication Study for Late-Life Depression

This is a 25-week study of the safety and effectiveness of duloxetine (Cymbalta) vs placebo (an inactive substance) in individuals who are age 65 or older.

Patient Inclusion Criteria:

• Male or female
• Age 65 or older
• Must meet criteria for depression
• Must be in generally good medical health

Patient Exclusion Criteria:

• Prior history of bipolar disorder, panic disorder, psychosis, schizophrenia or obsessive-compulsive disorder
• Severe dementia, mental retardation, or serious unstable medical condition
• History of excessive substance use in the past 6 months
• Prior history of lack of response to duloxetine for depression
• Uncontrolled narrow angle glaucoma
• Have discontinued hormone replacement therapy in the previous 3 months
• ECT or TMS within the past year

For More Information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.